Keywords
female genital schistosomiasis, acceptability, feasibility, self-sampling, self-collection, vaginal self-sampling, cervical self-sampling, genital self-sampling
female genital schistosomiasis, acceptability, feasibility, self-sampling, self-collection, vaginal self-sampling, cervical self-sampling, genital self-sampling
We have made changes based on the suggestions made by reviewers 1 and 2. Four additional edits have been made beyond those suggested. We noted a mistake in the introductory paragraph. S. haematobium infection, not FGS, has been associated with HIV-1 transmission and acquisition. To clarify, we have deleted this sentence. Second, in our comparison of the online manuscript with the submitted manuscript, we noted an additional paragraph online (Methods, page 5, section “Sample collection and questionnaire”), we have added this paragraph to the current version of the manuscript. Third, the previous flow table (Figure 2) contained the wrong number of virgins (it read 17 but should be 16). Figure 2 has been updated to reflect the change. Finally, in Table 3 the proportions of women preferring testing at home versus the clinic were mislabeled. This error has now been corrected.
As suggested by reviewer 1, we have included the Likert scale in the methods section of the manuscript and clarified that the questionnaires were not performed anonymously. To improve readability, we have also reduced the number of times the denominator of n=603 has been used throughout the text.
As suggested by reviewer 2, we have included information on sample site collection (at home), also Schistosoma infection status of our participants in the result section and corrected some minor editorial mistakes found in the discussion section. We have removed spoken languages from Table 1.
We have also included the recently published reference to the paper of the full methods of the BILHIV study.
See the authors' detailed response to the review by Peter Leutscher
See the authors' detailed response to the review by Alexander Odaibo
Human schistosomiasis is a waterborne parasitic disease caused by blood flukes of the genus Schistosoma1,2. It constitutes a significant public health problem causing the loss of 1,440 million years of full health worldwide, with approximately 659 million people at risk of acquiring infection2,3. More specifically, Schistosoma haematobium affects both the urinary as well as the genital tract. In female genital schistosomiasis (FGS)1, parasite egg deposition occurs in the genital tract and it is characterized by histologic vaginal or cervical mucosal inflammation4 and unique clinical findings5. FGS has been associated with infertility, a condition associated with negative social and psychological impacts in many low-income countries6. In addition, observational studies have suggested an association between FGS and prevalent HIV infection7,8, and HIV transmission and acquisition9.
Genital self-sampling has been described in the diagnosis of reproductive tract infections (RTI)10–12 in both adults and adolescents13 and has enhanced access to health services among hard-to-reach populations such as adolescents/young people14, and those who do not regularly access health screening services15,16. A high proportion of women, including those from resource-limited settings have been found to prefer vaginal specimen self-collection10,17 compared with clinic-based sampling. In addition to acceptability, two other factors make genital self-sampling advantageous; 1) the availability of vaginal self-sampling is effective for improving participation in specific RTI screening programmes and 2) the sensitivity of PCR-based assays on self-collected specimens compares favourably with physician-performed sampling16,18.
The Bilharzia and HIV (BILHIV) study’s primary aim was to validate home-based self-sampling for the detection of Schistosoma DNA with vaginal and cervical swabs against provider obtained cervicovaginal lavage in a clinic setting in an endemic area in Zambia. The BILHIV study previously found that Schistosoma DNA was more frequently detected in genital self-collected specimens compared to clinic-collected cervicovaginal lavage19. Here, we describe the acceptability and feasibility of genital self-sampling for the detection of Schistosoma DNA in the BILHIV study. In addition, this study also analyses the demographic predictors for participant’s preference of home-based self-sampling over clinic-based sampling.
The Bilharzia and HIV (BILHIV) study was a cross-sectional study nested within two of the 12 HPTN 071 (PopART) communities in Livingstone, southern province of Zambia20. HPTN 071 (PopART) was a trial to measure the impact of an HIV combination prevention package, including universal test and treat20. Non-pregnant, sexually active women aged 18-31 who had previously been recruited for the HPTN 071 (PopART) population cohort were eligible for inclusion in BILHIV.
Between January and August 2018, specially trained population cohort research assistants visited women during the population cohort 36-month end of study follow up and enquired regarding an “expression of interest” in the BILHIV study. At a subsequent home visit, BILHIV Community Workers (BCW) evaluated study eligibility, provided participants with study information in the language of their choice, along with FGS education, and obtained written informed consent.
At the home visit, conducted in each participant’s household, the BCW provided participating women with instructions for urine collection and cervical and vaginal self-swabs using educational materials including an information sheet with diagrams of the female anatomy, model vagina, and test swabs. Photos in the World Health Organization’s “Female Genital Schistosomiasis Pocket Atlas” were also displayed as a visual aid. As shown in Figure 1, these educational materials were used to explain and demonstrate the procedure of self-collection of genital specimens. For swab self-collection, participants were instructed to hold a 6-inch vaginal swab (PrimeSwab, Longhorn Diagnostics, Texas, USA) at the 2 3/8-inch score mark and insert the swab vaginally until their fingers touched the labia minora. Participants moved the swab in a circular motion against the vaginal walls for a minimum of 15 repetitions. Similarly, for the cervical swab, participants were instructed to hold a 6 3/4-inch flocked swab (Miraclean, Shenzen, China) with a quadrilateral kite-shaped tip at the non-flocked end of the swab body and insert the swab vaginally until they met noticeable resistance. The participant then performed swab rotation as described above. The participant broke the shaft of each swab and placed the vaginal and cervical swabs in separate screw-capped microtubes (STARLAB, Hamburg, Germany). Both swab specimens and urine were placed in cool boxes for transportation to the laboratory.

(A) The Bilharzia and HIV Community Workers (BCWs) demonstrating the use of genital self-swabs by using a 3D model; (B) BCWs teaching by using the WHO female genital schistosomiasis atlas; (C) BCWs delivering questionnaires in hand-held tablets. Photo credit: A. Bustinduy; oral permission was obtained from subjects to publish these images. Images have also been edited (pixelated and cropped) to keep the identity of the subjects anonymous.
Following written informed consent and specimen collection, the participants completed a non-anonymous questionnaire, with responses captured on hand-held tablets. The questionnaire assessed basic demographics, information regarding genital symptoms, sexual behaviour and also the participant’s assessment of the acceptability of self-sampling, through their responses to 15 questions each measured on a five-point Likert scale (Extended data21; Table 1).
| Characteristics | Overall (n=603) | Community A (n=319) | Community B (n=284) | p-value* | |
|---|---|---|---|---|---|
| Age in years – Median (IQR) | 24 (22-28) | 26 (23-29) | 24 (21-27) | <0.001 | |
| Marital Status | Single | 258 (42.8%) | 110 (34.5%) | 148 (52.1%) | <0.001 |
| Married or Cohabitating | 320 (53.1%) | 193 (60.5%) | 127 (44.7%) | ||
| Divorced or Separated | 23 (3.8%) | 15 (4.7%) | 8 (2.8%) | ||
| Widowed | 2 (0.3%) | 1 (0.3%) | 1 (0.4%) | ||
| Education (highest level) | Any Primary School | 167 (27.7%) | 117 (36.7%) | 50 (17.6%) | <0.001 |
| Any Secondary School | 364 (60.4%) | 173 (54.2%) | 191 (67.3%) | ||
| Training in a Trade | 59 (9.8%) | 20 (6.3%) | 39 (13.7%) | ||
| Degree or Higher | 3 (0.5%) | 3 (0.9%) | 0 (0.0%) | ||
| None | 10 (1.7%) | 6 (1.9%) | 4 (1.4%) | ||
| Employment status | Working | 408 (67.7%) | 200 (62.7%) | 208 (73.2%) | 0.006 |
| Not Working | 195 (32.3%) | 119 (37.3%) | 76 (26.8%) | ||
| Current water contact | None | 512 (84.9%) | 263 (82.5%) | 249 (87.7%) | 0.02 |
| At Least Weekly | 18 (3.0%) | 11 (3.5%) | 7 (2.5%) | ||
| Every 1–2 Months | 30 (5.0%) | 24 (7.5%) | 6 (2.1%) | ||
| Every 6–12 Months | 43 (7.1%) | 21 (6.6%) | 22 (7.8%) | ||
| Childhood water contact | None | 186 (30.9%) | 96 (30.1%) | 90 (31.7%) | 0.22 |
| At Least Weekly | 381 (63.2%) | 208 (65.2%) | 173 (60.9%) | ||
| Every 1–2 Months | 24 (4.0%) | 12 (3.8%) | 12 (4.2%) | ||
| Every 6–12 Months | 12 (2.0%) | 3 (0.9%) | 9 (3.2%) | ||
| No | 572 (94.8%) | 294 (92.2%) | 278 (97.9%) | 0.006 | |
| Self-reported history of schistosomiasis | Yes | 25 (4.2%) | 20 (6.3%) | 5 (1.8%) | |
| Maybe | 6 (1.0%) | 5 (1.6%) | 1 (0.4%) |
At a later date, participating women who were not currently menstruating attended Livingstone Central Hospital (LCH) cervical cancer screening clinic where a trained midwife performed a cervicovaginal lavage and images of the vagina and cervix were captured with a point-of-care colposcope (MobileODT, Tel Aviv Israel)19
All eligible participants providing written consent were recruited into the study. Participants who were unable to provide written informed consent were recruited in the presence of a witness with the participant placing their thumbprint on the consent form. The study was approved by the University of Zambia Biomedical Research Ethics Committee (reference number: 011-08-17), the Zambia National Health Research Authority and the London School of Hygiene and Tropical Medicine research ethics committee (reference number: 14506). Permission to conduct the study was given by the Livingstone District health office and the superintendent of the Livingstone Central Hospital.
Acceptability in our study was measured by the following outcomes: the proportion of women who rated home based self-sampling to be “easy” or “very easy” (for each of urine, vaginal, cervical self-sampling), the proportion who didn’t experience “pain” while self-sampling (for each of vaginal, cervical self-sampling), the proportion who were willing to self-sample again “in the future” (for each of urine, vaginal, cervical self-sampling), and the proportion who would prefer to “sample at home” (versus sampling in the clinic).
Participant data were entered using Open Data Kit Collect22. Continuous variables were summarized by mean and interquartile range (IQR), and categorical variables by frequency and percentage. Participant characteristics were compared between the two communities using Wilcoxon-Mann-Whitney, chi-squared, and Fisher’s exact tests. The Mantel-Haenszel approach was used to obtain crude and age-adjusted odds ratios for the association of demographic variables with a participant’s preference for home-based versus clinic-based sampling.
Of 1104 women screened for BILHIV eligibility, 54.5% (603/1105) were enrolled and all completed an initial home-based visit. Of those completing the initial home visit, 87.4% (527/603) completed clinic follow up visit (Figure 2). Unless otherwise stated, the denominator for the results presented reflects the total study enrolment of 603. The median age was 24 years (IQR 22-28). More than half of participants, 60.4% (364/603), completed secondary school education and 59% (356/603) spoke primarily Nyanja (Table 1). Active schistosome infection was determined by detectable urine Circulating Anodic Antigen (CAA) (15.1%, 91/601) or microscopy (5.5%, 33/603), as previously described18. Compared to clinic-collected CVL (14/527, 2.7%), Schistosoma DNA was more frequently detected in genital self-collected specimens (24/603, 4.0%)19.
Out of 603 women recruited, a high proportion indicated that self-collection of genital specimens was “easy” or “very easy” on a 5-point Likert scale for urine collection (96.2%; 580/603), vaginal swab (94.9%; 572/603), and cervical swab (86.6%; 522/603) (Figure 3; Table 2). Most participants indicated that they would be willing to self-collect again in the future: urine 97.0% (585/603), vaginal swab 96.7% (583/603) and cervical swab 96.5% (582/603). Substantially less than half of participants reported that it was “painful” to self-collect vaginal specimens (3.3%; 20/603) and cervical specimens (6.8%; 41/603) (Table 2). A high proportion of women (95.7%; 577/603) indicated that they would ‘recommend self-sampling to my friends’. Overall, most women preferred to collect specimens at home (90.0%; 543/603), compared with clinic-based sampling (10.0%; 60/603), (Table 3). Women from both communities preferred to self-collect specimens from home (Community A: 89.3%, 285/319; Community B: 90.9%, 258/284; p=0.5) compared with attending the health facility. Participants preferred “self-sampling at home” over provider-based sampling in the clinic due to greater privacy (65.0%, 353/543), convenience (51.4%, 279/543) and lack of transportation (17.7%, 96/543) (Table 3). Participants in Community B were more confident (99.3%; 282/284) than participants in Community A (91.5%; 292/319) (p<0.001) that they collected the specimens correctly.
| Question | Participant responses | % (n)* |
|---|---|---|
| Do you prefer to take your samples at home, or would you prefer to take samples at the clinic? | Clinic | 10.0 (60) |
| Home | 90.0 (543) | |
| I prefer doing samples at home because** | It is more convenient | 51.4 (279) |
| I don’t have transportation | 17.7 (96) | |
| I don’t have childcare | 2.6 (14) | |
| I need to work | 6.2 (34) | |
| I have more privacy at home | 65.0 (353) | |
| It is easier to sample at home | 66.3 (360) | |
| Other reason | 11.4 (62) | |
| I prefer having samples performed in clinic because** | I don’t have privacy at home | 26.7 (16) |
| I had discomfort with collecting my own samples | 13.3 (8) | |
| I was unsure if I did the sampling properly | 30.0 (18) | |
| I’d like more supervision | 28.3 (17) | |
| Other | 28.3 (17) |
Overall, there was little evidence that education, marital status, community of residence, employment status, language spoken, and age were associated with a participant’s preference for home-based sampling over clinic-based sampling (Table 4). Given that the preference for self-sampling was universal across the groups examined in the crude analysis, we did not undertake multivariable analysis.
Vulnerable women and girls in sub-Saharan Africa are afflicted by FGS, a chronic gynaecologic condition. Current diagnostic strategies are limited as they rely on resources that are seldom available in low-income settings23. A self-collection method that minimises reliance on health care providers would represent a scalable alternative method for FGS community-based diagnosis in endemic resource limited settings, but only if it is an acceptable procedure to perform. However, barriers to FGS diagnosis still remain, including costs, limited access to point-of-care diagnostics, and challenges with maintaining the cold chain. The cost of genital swabs (0.50$/vaginal swab and 0.30$/cervical swab) and molecular testing (6.68$/test) may be affordable in some research settings, but more field-appropriate and scalable methods should be investigated. Home based genital self-sampling for the diagnosis of FGS was highly acceptable among women aged 18 to 31 years of age enrolled in the BILHIV study in Zambia. All participating women provided all three self-collected specimens (urine, vaginal and cervical swabs), and a high proportion found vaginal self-sampling and cervical self-sampling “easy” or “very easy”.
Our study is in agreement with other studies in which self-swabs were acceptable to women in geographically and ethnically diverse target populations10,18,24. In a study of Haitian immigrants living in the USA, the acceptability of unsupervised cervical HPV self-sampling using written instructions revealed that self-sampling was more acceptable to the majority of the women than clinician-administered sampling24,25, and it increased screening coverage among female clinic non-attendees15,26. Also in an Italian study, cervical self-sampling using either a brush or a self-lavaging device was acceptable and both modalities were preferred to clinician-sampling (n=117, 68%)27. A systematic review on the acceptability of self-sampled screening for HPV DNA reported that self-sampling was highly acceptable among study participants in 37 studies from 24 countries across five continents25. Despite heterogeneity in study design, the studies in this meta-analysis suggest that self-sampling is well accepted by participants regardless of education, marital status, community of residence, employment status, language spoken, and age. Supported by these data we can conclude that our findings are likely generalizable across geographic areas and among women of varying educational background, cultures, and ethnic groups.
Substantially over half of the women in the BILHIV study reported that self-collection of specimens was “easy” or “very easy” (urine 96.2%, vaginal swab 94.9% and cervical swab 86.6%). This is consistent with other studies that showed that study participants found genital self-sampling or the use of a self-sampling device easy to use24,25. The proportion with this outcome was slightly lower for cervical than vaginal sampling. Swab length and more invasive technique may account for the lower proportion of women who found cervical self-sampling “easy” or “very easy”, compared with vaginal self-sampling. As another measure of acceptability, over 96% of women in the BILHIV study indicated that they were willing to self-collect all three specimens again in the future, which is similar to proportions reported in HPV self-collection research using cervical swabs24,28 and curable STI research using vaginal swabs29. Our study, as others, further showed that a high proportion of the women indicated that they would recommend self-sampling to a friend25. This shows promise for the future use of peer-encouragement in the use of genital self-sampling procedures.
Our study also revealed that 90.0% of participants preferred self-sampling at home over provider-based sampling at the clinic. Our findings are similar to studies reporting a high preference for home self-sampling25,27,28. However, a recent meta-analysis found that the pooled estimate of women who preferred self-sampling to clinic based sampling was 59% (48 – 69%)25. There are some possible explanations for this. While a binary outcome was evaluated in the meta-analysis, the individual reasons for preferring home-based self-sampling to health-facility sampling vary across studies. In the BILHIV study questionnaire, the questions regarding preferences for home vs. clinic sampling included a comprehensive range of options that included ‘privacy’, ‘convenience’, ‘transportation’, ‘work conflicts’, ‘no child-care’, and ‘ease’ among others. Second, other work reports that some women preferred clinic sampling to home based self-sampling because they were not comfortable with touching their genital areas, they were unsure about the safety of self-testing, or they were concerned they would perform the test incorrectly30.
This study benefited from HPTN 071 (PopART) because HPTN 071 (PopART) staff introduced the BILHIV study to all prospective BILHIV participants that enabled them to be familiar with the study even before it began. Further, the BILHIV study was implemented in communities that were already familiar with the organization and the staff that worked under the HPTN 071 (PopART) study. In addition, former HPTN 071 (PopART) staff in the two study communities continued to work in the same communities under the BILHIV study. This enabled improved study performance because of the existing rapport between BILHIV staff and the community members. Standardized questionnaires were used to reduce observer bias and were performed at the time of self-sampling to minimize recall bias. However, it is important to note that the participation in the BILHIV study was limited to women who took part in the HPTN 071 (PopART) population cohort. In this scenario, bias may be related to a Hawthorne effect. This observer effect can occur as participants in a study alter their behaviour as a result of regular follow-up within a cohort31. The HPTN 071 (PopART) population cohort was selected through a random sampling of households and random selection of one individual within each household31. BILHIV study participants were selected by querying eligible members of the population cohort for an “expression of interest”. There may be selection bias, in that women who expressed an interest in participating in the study may not be representative of the population as a whole and findings may not be generalizable to other sub-Saharan African communities. A larger study of genital self-sampling should be performed, preferably in areas of varied schistosomiasis endemicity.
We have shown high acceptability and feasibility of genital self-sampling for the diagnosis of FGS in young women (18–31 years) in a schistosomiases endemic area in Zambia. This practice has potential to increase FGS surveillance in other endemic populations. The majority of participants reported that specimen self-collection was “easy” or “very easy” with high willingness to participate in future home-based self-sampling. Results can inform future efforts for community-based diagnosis of FGS.
LSHTM Data Compass: BILHIV acceptability dataset, https://doi.org/10.17037/DATA.0000161832.
This data is under restricted access due to the assurance given to participants that responses would be kept completely confidential. This is particularly important due to the sensitivity of the data produced. The data set can be accessed by completing the Request Form, which requires that the intended use for the data is specified. Data available under the LSHTM Data Compass Data Sharing Agreement.
Figshare: Extended data_Figshare.docx, https://doi.org/10.6084/m9.figshare.12023382.v121.
We wish to warmly acknowledge the BILHIV study participants, without whom this work would not have been possible.
BILHIV study team: https://www.lshtm.ac.uk/research/centres-projects-groups/bilharzia-and-hiv
| Views | Downloads | |
|---|---|---|
| Wellcome Open Research | - | - |
Data from PMC are received and updated monthly. | - | - |
Competing Interests: No competing interests were disclosed.
Competing Interests: No competing interests were disclosed.
Reviewer Expertise: Epidemiology and control of schistosomiasis.
Is the work clearly and accurately presented and does it cite the current literature?
Yes
Is the study design appropriate and is the work technically sound?
Yes
Are sufficient details of methods and analysis provided to allow replication by others?
Partly
If applicable, is the statistical analysis and its interpretation appropriate?
I cannot comment. A qualified statistician is required.
Are all the source data underlying the results available to ensure full reproducibility?
Yes
Are the conclusions drawn adequately supported by the results?
Yes
Competing Interests: No competing interests were disclosed.
Reviewer Expertise: Epidemiology and control of schistosomiasis.
Is the work clearly and accurately presented and does it cite the current literature?
Yes
Is the study design appropriate and is the work technically sound?
Yes
Are sufficient details of methods and analysis provided to allow replication by others?
Yes
If applicable, is the statistical analysis and its interpretation appropriate?
Yes
Are all the source data underlying the results available to ensure full reproducibility?
Yes
Are the conclusions drawn adequately supported by the results?
Yes
Competing Interests: No competing interests were disclosed.
Alongside their report, reviewers assign a status to the article:
| Invited Reviewers | ||
|---|---|---|
| 1 | 2 | |
| Version 2 (revision) 02 Sep 20 | read | read |
| Version 1 02 Apr 20 | read | read |
Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list:
Sign up for content alerts and receive a weekly or monthly email with all newly published articles
Register with Wellcome Open Research
Already registered? Sign in
If you are a previous or current Wellcome grant holder, sign up for information about developments, publishing and publications from Wellcome Open Research.
We'll keep you updated on any major new updates to Wellcome Open Research
The email address should be the one you originally registered with F1000.
You registered with F1000 via Google, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Google account password, please click here.
You registered with F1000 via Facebook, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Facebook account password, please click here.
We have sent an email to , please follow the instructions to reset your password.
If you don't receive this email, please check your spam filters and/or contact .
Comments on this article Comments (0)